Optimal management of atypical hemolytic uremic disease: challenges and solutions

Atypical hemolytic uremic syndrome (aHUS) is a chronic life threatening condition that arises from genetic abnormalities resulting in uncontrolled complement amplifying activity. The introduction of eculizumab, the humanized monoclonal antibody, has brought about a paradigm shift in the management o...

Descripción completa

Detalles Bibliográficos
Autores principales: Raina, Rupesh, Grewal, Manpreet K, Radhakrishnan, Yeshwanter, Tatineni, Vineeth, DeCoy, Meredith, Burke, Linda LG, Bagga, Arvind
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732511/
https://www.ncbi.nlm.nih.gov/pubmed/31564951
http://dx.doi.org/10.2147/IJNRD.S215370

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6732511/
https://www.ncbi.nlm.nih.gov/pubmed/31564951
http://dx.doi.org/10.2147/IJNRD.S215370

Ejemplares similares